Advertisement
UK markets closed

  • FTSE 100

    7,814.16
    -151.37 (-1.90%)
     

  • FTSE 250

    19,365.58
    -333.31 (-1.69%)
     

  • AIM

    740.18
    -10.10 (-1.35%)
     

  • GBP/EUR

    1.1701
    -0.0010 (-0.08%)
     

  • GBP/USD

    1.2434
    -0.0012 (-0.10%)
     

  • Bitcoin GBP

    49,874.26
    -2,023.12 (-3.90%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,059.78
    -2.04 (-0.04%)
     

  • DOW

    37,875.58
    +140.47 (+0.37%)
     

  • CRUDE OIL

    85.62
    +0.21 (+0.25%)
     

  • GOLD FUTURES

    2,401.70
    +18.70 (+0.78%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     

  • DAX

    17,746.52
    -280.06 (-1.55%)
     

  • CAC 40

    7,921.97
    -123.14 (-1.53%)
     
Money:

How to avoid tax creep in retirement

The state pension went up 8.5% in April, but frozen thresholds mean pensioners will be paying more tax

Options Traders Expect Huge Moves in Keryx (KERX) Stock

Zacks Equity Research
Updated
Is (LXFR) Outperforming Other Industrial Products Stocks This Year?

Investors in Keryx Biopharmaceuticals, Inc. KERX need to pay close attention to the stock based on moves in the options market lately. That is because the March 16, 2018 $3.50 Put had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Keryx shares, but what is the fundamental picture for the company? Currently, Keryx is a Zacks Rank #4 (Sell) in the Medical - Biomedical and Genetics industry that ranks in the Bottom 25% of our Zacks Industry Rank. Over the last 60 days, no analyst has increased the earnings estimates for the current quarter, while one analyst has dropped its estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of 9 cents per share to a loss of 19 cents in that period.

Given the way analysts feel about Keryx right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?

Each week, our very own Dave Bartosiak gives his top options trades. Check out his recent live analysis and options trade for the NFLX earnings report completely free. See it here: Bartosiak: Trading Netflix's (NFLX) Earnings with Options or check out the embedded video below for more details:


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Keryx Biopharmaceuticals, Inc. (KERX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research